STOCK TITAN

Forager Capital Management Denies its Offer was Unsolicited and Requests that Quipt Terminate its Standstill Agreement

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Forager Capital Management, a major shareholder of Quipt Home Medical Corp (NASDAQ:QIPT), is demanding Quipt retract its May 21 press release that characterized Forager's $3.10 per share acquisition offer as 'unsolicited.' Forager argues that the Chairman of Quipt's Board invited them to make an offer via email on May 15, 2025, and they acted in accordance with their Non-Disclosure and Standstill Agreement. Forager claims Quipt is misusing the Agreement to portray them negatively while preventing disclosure of material facts to shareholders. They are requesting immediate termination of the Agreement to allow shareholders to evaluate value-enhancing offers.
Forager Capital Management, uno dei principali azionisti di Quipt Home Medical Corp (NASDAQ:QIPT), chiede a Quipt di ritirare il comunicato stampa del 21 maggio che definiva l'offerta di acquisto di Forager a 3,10 dollari per azione come "non sollecitata". Forager sostiene che il Presidente del Consiglio di Amministrazione di Quipt li ha invitati a presentare un'offerta tramite email il 15 maggio 2025, e che hanno agito in conformità con il loro Accordo di Non Divulgazione e Standstill. Forager accusa Quipt di utilizzare impropriamente l'Accordo per rappresentarli in modo negativo, impedendo al contempo la divulgazione di fatti rilevanti agli azionisti. Chiedono la cessazione immediata dell'Accordo per consentire agli azionisti di valutare offerte che aumentano il valore.
Forager Capital Management, un accionista importante de Quipt Home Medical Corp (NASDAQ:QIPT), está exigiendo que Quipt retire su comunicado de prensa del 21 de mayo que calificaba la oferta de adquisición de Forager de 3,10 dólares por acción como "no solicitada". Forager argumenta que el Presidente de la Junta de Quipt los invitó a hacer una oferta por correo electrónico el 15 de mayo de 2025, y que actuaron conforme a su Acuerdo de Confidencialidad y Standstill. Forager afirma que Quipt está haciendo un mal uso del Acuerdo para retratarlos negativamente mientras impide la divulgación de hechos materiales a los accionistas. Solicitan la terminación inmediata del Acuerdo para permitir que los accionistas evalúen ofertas que aumenten el valor.
Forager Capital Management는 Quipt Home Medical Corp(NASDAQ:QIPT)의 주요 주주로서, 2025년 5월 21일 Quipt가 Forager의 주당 3.10달러 인수 제안을 '비공식적'이라고 표현한 보도자료를 철회할 것을 요구하고 있습니다. Forager는 Quipt 이사회 의장이 2025년 5월 15일 이메일로 제안 제출을 요청했으며, 자신들은 비밀유지 및 스탠드스틸(거래 중단) 계약에 따라 행동했다고 주장합니다. Forager는 Quipt가 해당 계약을 부적절하게 이용해 자신들을 부정적으로 묘사하고 주주들에게 중요한 사실 공개를 막고 있다고 비판합니다. 이에 Forager는 주주들이 가치 향상 제안을 평가할 수 있도록 계약의 즉각적인 종료를 요청하고 있습니다.
Forager Capital Management, un actionnaire majeur de Quipt Home Medical Corp (NASDAQ:QIPT), exige que Quipt retire son communiqué de presse du 21 mai qualifiant l'offre d'acquisition de Forager à 3,10 $ par action d'« inopinée ». Forager soutient que le président du conseil d'administration de Quipt les a invités à faire une offre par e-mail le 15 mai 2025, et qu'ils ont agi conformément à leur accord de confidentialité et de standstill. Forager affirme que Quipt utilise cet accord de manière abusive pour les dépeindre négativement tout en empêchant la divulgation d'informations importantes aux actionnaires. Ils demandent la résiliation immédiate de l'accord afin de permettre aux actionnaires d'évaluer des offres susceptibles d'accroître la valeur.
Forager Capital Management, ein bedeutender Aktionär von Quipt Home Medical Corp (NASDAQ:QIPT), fordert Quipt auf, die Pressemitteilung vom 21. Mai zurückzuziehen, in der Foragers Übernahmeangebot von 3,10 USD pro Aktie als „unaufgefordert“ bezeichnet wurde. Forager argumentiert, dass der Vorsitzende des Quipt-Vorstands sie am 15. Mai 2025 per E-Mail eingeladen habe, ein Angebot abzugeben, und dass sie im Einklang mit ihrer Geheimhaltungs- und Stillhaltevereinbarung gehandelt hätten. Forager behauptet, Quipt missbrauche die Vereinbarung, um sie negativ darzustellen und gleichzeitig die Offenlegung wesentlicher Fakten gegenüber den Aktionären zu verhindern. Sie fordern die sofortige Beendigung der Vereinbarung, damit die Aktionäre wertsteigernde Angebote prüfen können.
Positive
  • Forager's offer represents a potential acquisition opportunity for shareholders
  • Forager claims to have followed proper procedures under the Agreement for making their offer
Negative
  • Dispute between major shareholder and management could create uncertainty
  • Potential legal complications due to disagreement over Agreement terms
  • Conflict over disclosure restrictions may limit shareholder access to material information

Insights

Forager disputes Quipt's characterization of its takeover bid, revealing shareholder-management conflict over a $3.10/share offer.

This press release highlights a significant dispute between Forager Capital Management, a major shareholder of Quipt Home Medical, and Quipt's management regarding Forager's $3.10 per share acquisition offer. Forager is challenging Quipt's May 21 characterization of their offer as "unsolicited," arguing this depiction is misleading based on previous communications.

The dispute centers around a Non-Disclosure and Standstill Agreement from February 2025. Forager claims the Chairman of Quipt's Board invited them to make an offer on May 15, which they interpreted as permission under Section 9 of their agreement. This directly contradicts Quipt's public stance.

What's particularly concerning is Forager's accusation that Quipt is using the agreement in a contradictory manner - using one section to paint Forager as a "bad actor" while using another section to prevent Forager from disclosing material facts to shareholders. This suggests potential corporate governance issues and raises questions about management's transparency.

The 100% acquisition offer represents a significant premium to Quipt's recent trading price, which has been depressed amid challenging conditions in the home medical equipment sector. Forager's explicit statement that its priority is "value crystallization for shareholders" signals they believe the company is undervalued under current management.

This situation reveals growing tensions between a significant shareholder and management, with Forager now publicly requesting termination of their standstill agreement - a move that would allow them to communicate directly with other shareholders and potentially launch a more aggressive takeover campaign.

BIRMINGHAM, AL / ACCESS Newswire / June 4, 2025 / Forager Capital Management ("Forager"), one of the largest shareholders of Quipt Home Medical Corp. ("Quipt") (NASDAQ:QIPT)(TSX:QIPT), requests that Quipt immediately and unequivocally retract its false and misleading statement made in its press release on May 21, 2025 relating to Forager's offer to acquire 100% of Quipt's issued and outstanding common shares at a price of $3.10 per common share. Forager's priority is value crystallization for shareholders and correcting misinformation-not engaging in a public dispute with Quipt.

Quipt's characterization of Forager's May 17, 2025 Letter of Intent as "unsolicited" is disingenuous. Section 9 of the Non-Disclosure and Standstill Agreement entered on February 1, 2025 (the "Agreement") states that Forager is permitted to make an offer with advance written notice from the Quipt Board of Directors. Forager received an email from the Chairman of the Board of Directors on May 15, 2025 inviting Forager to access additional data so it could make its best offer. Forager determined it had sufficient data to formulate its offer and interpreted the Chairman's email as a good-faith invitation to engage and responded accordingly. Moreover, Forager gave the Board prompt notice pursuant to Section 6 of the Agreement to which Forager never received any objection.

Quipt is using Section 9 of the Agreement to paint Forager as a bad actor and to suggest to shareholders that Forager is prohibited from making an offer, while simultaneously using Section 1 to prevent Forager from disclosing relevant, material facts to those same shareholders. Shareholders deserve the opportunity to receive and evaluate all offers that increase shareholder value.

Forager requests that Quipt terminate the Agreement. This request is costless and overwhelmingly in the best interest of shareholders.

Media Contact Info:

Johnny Wilhelm, Partner
Forager Capital Management, LLC
info@foragercap.com

SOURCE: Forager Capital Management



View the original press release on ACCESS Newswire

FAQ

What is Forager Capital Management's offer price for Quipt Home Medical (QIPT)?

Forager Capital Management offered to acquire 100% of Quipt's issued and outstanding common shares at $3.10 per common share.

Why is Forager requesting Quipt to retract its May 21, 2025 press release?

Forager claims Quipt falsely characterized their acquisition offer as 'unsolicited' when they had received prior invitation from Quipt's Board Chairman to make an offer.

What is the main dispute between Forager Capital and Quipt Home Medical (QIPT)?

The dispute centers on whether Forager's acquisition offer was properly solicited under their Agreement, and Forager claims Quipt is using the Agreement to restrict information disclosure while portraying Forager negatively.

What is Forager requesting from Quipt Home Medical (QIPT)?

Forager is requesting that Quipt terminate their Non-Disclosure and Standstill Agreement and retract their May 21, 2025 press release.

When did Quipt's Chairman allegedly invite Forager to make an offer?

According to Forager, Quipt's Chairman sent an email on May 15, 2025, inviting them to access additional data to make their best offer.
Quipt Home Medical Corp

NASDAQ:QIPT

QIPT Rankings

QIPT Latest News

QIPT Stock Data

76.90M
36.56M
9.49%
61.19%
3.57%
Medical Devices
Services-misc Health & Allied Services, Nec
Link
United States
WILDER